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Abstract At least during the first 6 months after birth, the
nutrition of infants should ideally consist of human milk which
provides 40–60 % of energy from lipids. Beyond energy,
human milk also delivers lipids with a specific functionality,
such as essential fatty acids (FA), phospholipids, and choles-
terol. Healthy development, especially of the nervous and
digestive systems, depends fundamentally on these. Epidemio-
logical data suggest that human milk provides unique health
benefits during early infancy that extend to long-lasting bene-
fits. Preclinical findings show that qualitative changes in dietary
lipids, i.e., lipid structure and FA composition, during early life
may contribute to the reported long-term effects. Little is
known in this respect about the development of digestive
function and the digestion and absorption of lipids by the
newborn. This review gives a detailed overview of the distinct
functionalities that dietary lipids from human milk and infant
formula provide and the profound differences in the physiology
and biochemistry of lipid digestion between infants and adults.
Fundamental mechanisms of infant lipid digestion can,
however, almost exclusively be elucidated in vitro. Experimen-
tal approaches and their challenges are reviewed in depth.
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The Developing Digestive System
Birth constitutes a dramatic switch in the supply of nutrients
from the placenta to the gut and, with the first feeding, the
exposure of the gastrointestinal system to something differ-
ent from amniotic fluid. This transition generates the neces-
sity to digest macronutrients prior to their absorption and
makes the gut, with its large, folded surface, our biggest
interface to the outside world. In essence, very little is
known about the complex development of digestive func-
tions in human newborns. This is not surprising, since the
clinical investigation of digestive processes frequently
requires invasive procedures, such as the usage of nasogas-
tric and nasoduodenal tubes or the drawing of blood sam-
ples. Their invasiveness limits the applicability of such
procedures in healthy term infants. Preterm infants are usu-
ally fed via a gastric tube that also allows the collection of
samples. As a result, lipid digestion has, to the best of our
knowledge, only been functionally investigated in preterm
infants, but not term infants [12, 128].
Lipids comprise a broad group of small molecules that,
besides fats (here defined as triacylglycerols (TAGs)), in-
clude other hydrophobic or amphiphilic compounds, such as
phospholipids (PLs), monoacylglycerols and diacylglycer-
ols (MAGs and DAGs), and sterols. The functionality of
these has been reviewed elsewhere in detail [83, 84]. How-
ever, from stool samples, it can be concluded that lipids are
not completely absorbed by infants. The amount of fat that
is excreted with the stool can approximate 10 % in term
infants and 10–30 % in preterm infants [9, 14, 37, 38, 42,
91, 138, 157]. The amount of unabsorbed fat appears to
depend essentially on gestational and postnatal age and the
type of fat [126]. This is likely to be linked to the maturation
of the digestive system, be it the digestive function (i.e.,
enzyme and bile salt (BS) levels), absorptive capacity, or a
combination of both.
Infant Lipid Digestion and Microbiota Composition
Unabsorbed lipids are transported to the colon where they
might influence or be utilized by the colonic microbiota.
The latter has been extensively credited for its relevance in
health and disease. It provides nutrients and energy through
the fermentation of dietary and endogenous components
[43]. During the first year of life, the dietary influence on
the development of microbiota composition and functional-
ity has been extensively studied. As such, human milk
oligosaccharides have been identified to be critical for shap-
ing the gut’s microbiota composition [27, 82]. In infants, the
specific effect of unabsorbed long-chain fatty acids (LCFA)
on the colonic microbiota is likely to be masked by the
continuous supply of prebiotic oligosaccharides. It has
actually been demonstrated that the effect of fish oil on
infant’s microbiota is only detectable after ceasing human
milk feeding [7]. Although the impact of a high-fat diet on
human or rodent microbiota has been widely documented,
the influence of undigested LCFA on microbiota function in
infants remains to be elucidated [7, 80, 118, 140].
Lipids in Human Milk and Infant Formula
Interestingly, the aforementioned fecal fat excretion has
been found to be higher in infant formula (IF)-fed infants
than in breast-fed infants [14, 42]. In addition, it was con-
cluded in two studies that gastric TAG hydrolysis from
human milk is 1.7 to 2.5 times higher than that of IF, while
gastric pH, emptying, and enzyme output were not different
in these infants [12, 128] (Fig. 1). It is likely that most of
these findings are related to the differences in the quality
and composition of lipids in human milk compared to IFs.
Lipids are intricately packed in human milk. Human
milk fat is secreted as milk fat globules (MFGs) from
the alveolar epithelial cells of the lactating mammary
gland. The human MFGs have a typical diameter of 3–
9 μm. MFGs consist of a hydrophobic core comprising
mainly of TAGs, which is enveloped by a triple layer of
amphipathic compounds, such as PLs, proteins, includ-
ing enzymes, and cholesterol, which together assemble
the milk fat globule membrane (MFGM) [84, 94, 110,
114, 129] (Fig. 2). A comparison of the lipids in mature
human milk and those in current IFs shows differences in fatty
acid (FA) composition and in their physical structure. The fat
droplets in IF are usually much smaller in size, about 0.4 μm,
and lack the membrane envelope [110, 137].
The content and composition of human milk fat varies
and has been found to depend among other factors on the
mother’s diet and the stage of lactation. Human milk total
lipid content increases during lactation from 2 g/dL in
colostrum to 4.9 g/dL in mature milk and adapts to the
needs of the growing child [102]. Human milk has an
average total lipid content of about 3.8–3.9 g/100 ml. About
98 % of human milk’s total lipid content is TAGs, which
serve mainly as an energy source for the fast-growing infant.
The remaining fat is a complex mix of polar lipids, including
PLs, glycolipids and sphingolipids, fat-soluble vitamins, cho-
lesterol and cholesterol esters, and small amounts of lipolysis
products, such as free fatty acids (FFAs), MAGs, and DAGs.
These lipids deliver important functional materials, such as the
building blocks for cellular membranes in various tissues,
antioxidants, and signaling molecules. In human milk, polar
lipids account for 0.8–2.2 %, and cholesterol for about 0.5 %
of the lipids. The various polar lipid species include sphingo-
myelin (37.5 %), phosphatidylcholine (28.4 %),
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phosphatidylethanolamine (27.7 %), phosphatidylserine
(8.8 %), and phosphatidylinositol (6.1 %) [84].
The TAG composition of human milk fat resembles that
of mature adipose tissues. Hence, it contains a ratio of
saturated over unsaturated fat that is appropriate for cell
membrane function and has a melting point around body
temperature [32]. The main FAs found in human milk are
palmitic acid (PA, C16:0, 26.5 %) and oleic acid (OA,
C18:1 n-9, 35.5 %). The essential FA linoleic acid (LA,
18:2 n-6, 7.2 %) is the most abundant polyunsaturated fatty
acid (PUFA), followed by the other essential PUFA α-
linolenic acid (ALA, 18:3 n-3, 0.8 %) [102]. In recent years,
the long-chain polyunsaturated fatty acids (LCPUFAs)
arachidonic acid (AA, 20:4 n-6, 0.3–1.0 %) and docosahex-
aenoic acid (DHA, 22:6 n-3, 0.1–0.9 %) have been credited
as important functional components in human milk [78].
These LCPUFAs are not only necessary for normal brain
development, with its peak from the last trimester of preg-
nancy and the first year(s) of life, but also for immune
function [33, 83]. Average n-6 to n-3 ratios of 5 to 10 have
been observed in human milk. These increased up to a ratio
of 18 if corn, sunflower, or safflower oils were enriched in
the mother’s diet. The AA:DHA ratio is usually between 1:1
and 2:1. Eicosapentaenoic acid (EPA) is only found in
minimal amounts in human milk, except for populations
with high sea fish intakes [78]. Initially, IFs were not sup-
plemented with LCPUFAs as it was assumed that infants
could synthesize these FAs from their precursors and young
infants appear to be able to convert ALA to DHA and LA to
AA [57]. In neonates, the enzymatic activity to form these
LCPUFAs may nonetheless be too limited to meet, for
example, the high requirements of these building blocks
for the developing neural tissue. Therefore, supplementation
of IFs with LCPUFAs is now widely recommended.
A relatively large proportion (15–20 %) of LCPUFAs in
human milk is provided through the PL fraction, although
most of the LCPUFAs are esterified to TAGs because of the
considerably higher total amount of the latter [65]. Hence,
differences in the physicochemical properties of LCPUFAs
linked to either TAGs or PLs suggest different absorption
mechanisms and deviat ing biological funct ions.
Fig. 1 Gastric lipolysis was investigated in breast fed (a), and two
groups of formula fed preterm infants ((b) SMA SP and (c) Similac
SC). Data are given as mean±SE. Different superscript letters indicate
significant differences. From [12]
Fig. 2 Structure of the human milk fat globule membrane (MFGM). A
trilayer of polar lipids forms the backbone of the MFGM. (PC phos-
phatidylcholine; PE phosphatidylethanolamine; PS phosphatidylser-
ine; PI phosphatidylinositol). From [93]
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Consequently, the dietary source of LCPUFAs could be of
biological significance for the developing infant. Direct evi-
dence for this is given in nonhuman primates. It has been
shown that dietary AA-PL is at least as efficacious as dietary
AA-TAG to supply the developing organs with AA [155]. No
direct information relates to the effects of DHA-TAG versus
DHA-PL in this context [2, 5, 6, 38, 58, 106, 155].
Various FAs have a preference for their linkage to the
glycerol core molecule in a specific position. This has been
found to depend on their carbon atom chain length and their
degree of saturation. In human milk TAGs, the most abun-
dant saturated FA (PA) exhibits a high preference for the sn-
2 position of 60–70 %. The sn-1 and sn-3 positions of
human milk TAGs are commonly occupied by unsaturated
FAs, such as OA and LA, as well as medium-chain FAs
(mainly 12:0). Contrarily, today, most IFs contain much
higher amounts of PA in the sn-1 or sn-3 position of the
TAGs [139]. This difference in the localization of a specific
FA in the TAGs might be crucial for the metabolization of
dietary fat by infants. For instance, it has been shown that,
due to a decreased calcium soap formation, fat and calcium
absorption can be improved in IFs containing PA in the sn-2
position, compared to IFs with PA in the sn-1 or sn-3
position [37, 90].
Lipid Architecture and Nutritional Programming
Human milk has a highly complex lipid architecture. Human
epidemiological studies that compare breast-fed and
formula-fed infants suggest a moderate protective effect of
human milk against rapid growth during the first year after
birth and the risk of cardiovascular and metabolic disease
later in life [131]. It was hypothesized that the specific
surface composition and size of the lipid droplets in human
milk may contribute to the reported long-term benefits of
breastfeeding.
To test this hypothesis, a concept IF was developed with
lipid droplets that exhibit physical properties similar to those
in human milk, i.e., larger in size and coated with PL
(Nuturis®) and tested in a mouse model of nutritional
programming [120, 143]. Studies showed comparable body
weight (BW) and gain in absolute and relative fat mass
between Nuturis® and control groups directly after early
diet intervention. The postnatal Nuturis®-containing diet
reduced, however, the increase in fat mass gain by a subse-
quent Western-style diet challenge by 30 % [121]. These
results suggest that qualitative changes in dietary fat in early
life, such as fat structure and FA composition, may have a
significant contribution to the early development of body
composition [120]. This knowledge on the functionality of
fat quality in the early diet may contribute to an improved
understanding of childhood overweight and obesity risks
and may help to develop a preventative strategy for future
generations. The lasting effects of fat globule architecture in
nutritional compositions during infancy on metabolic func-
tions later in life illustrate the complexity of the subject
matter. These effects might ultimately be linked to changes
in digestion due to changes in physical structure.
Physiology and Enzymology of Lipid Digestion
in Infancy
Human milk is relatively rich in lipids. Surprisingly, this
does not match with the relatively low levels of pancreatic
TAG lipase (PTL) and BSs that one may expect to be
required for their digestion [161]. The digestive physiology
of newborns deviates from that of adults beyond the smaller
size of the different digestive organs [1, 81]. Based on
distinct requirements, the quality and quantity of enzymes
and bile, pH values, gut permeability, and meal and eating
patterns differ considerably between infants and adults. As
such, infant lipid digestion relies on lipases other than PTL,
such as gastric lipase (GL), bile salt-dependent lipase
(BSDL, also called carboxyl esterase lipase), and pancreatic
lipase-related protein 2 (PLRP2) [8, 64, 91]. Moreover,
human milk also contains bile salt-stimulated lipase
(BSSL), which is an enzyme with close similarity to the
pancreatic BSDL [91].
Compared to adults, gastric lipid digestion has a more
prominent function in young infants. Lipolysis by GL starts
in the stomach after ingestion [41]. In newborns, GL activity
(units per volume) is found to be slightly lower or compa-
rable to that of adults fed a high-fat diet, which may also
depend on the used activity assay [11, 12, 128]. GL is
secreted by the chief cells in the fundus of the stomach
and has a preference for FAs on the sn-3 position of the
TAG. This stereo-preference results in an apparent specific-
ity for short-chain FAs, as the short-chain and medium-
chain FAs are located on the sn-3 position in milk TAGs
[18, 55, 127, 128]. GL has a high activity in a broad pH
range. Its pH optimum is at a pH between 5.4 and 5.8, and
the enzyme is resistant to low pH values. The acidification
in the infant’s stomach is slower compared to that of adults,
which brings the gastric pH closer to the optimum of the
lipase [63, 128, 132, 147]. The enzyme retains part of its
activity in the small intestine which broadens its contribu-
tion to lipid digestion [4, 39, 89, 128]. GL activity can
account for 10–30 % of dietary TAG hydrolysis in adults
and up to 60 % of dietary TAG hydrolysis in infants [39, 41,
62, 128, 141]. However, FFAs that are protonated at the low
pH in the stomach can also form layers adsorbed onto the fat
droplet, which limits gastric lipolysis [56, 122]. The FFAs
generated in the stomach by GL can furthermore suppress
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microbial growth in absence of efficient acidification by
hydrochloric acid [77].
While the pH of the stomach declines, the mixture of
digestive juices and food, now called chyme, is emptied into
the duodenum. The gastrointestinal tract reacts to the acidic
and nutrient-rich chyme with the aim to neutralize its pH, to
control the entry of nutrients, and to activate the secretion of
bile and pancreatic fluid [18]. The latter contains a broad
range of enzymes and bicarbonate, which neutralizes the
acidic gastric effluent. Pancreatic digestive enzymes found
in infants are among others (1) amylolytic (α-amylase), (2)
proteolytic (trypsin, chymotrypsin, and elastase), and (3)
lipolytic (PTL, BSDL, PLRP2, and phospholipase A2
(PLA2)) [26, 60, 61, 87, 95, 107]. As the name indicates,
BSDL is activated by bile, while it does not need colipase
for activation. PLRP2 has activity against TAGs, PLs, and
galactolipids [46]. Its activity is influenced by colipase
[158]. PTL does not hydrolyze the ester bond at the sn-2
position of TAG. BSDL and PLRP2 contrarily have no
preference for the sn-1, sn-2, or sn-3 position of the FA
[91, 150]. Lipolysis by these enzymes may thus result in
only FFAs and glycerol. The digestive lipases operate syn-
ergistically in the digestion of emulsified fat. Hence, the
liberation of FAs by GL in the stomach contributes to the
onset of lipolysis by pancreatic colipase-dependent lipases
and BSDL [18, 19, 56].
PLA2 hydrolyzes PLs that cover TAG droplets into the
more polar and surface-active monoacyl PL. This releases
FFAs, which turn the triglyceride droplet into a better substrate
for PTL [30]. This synergy is of direct importance for the
digestion of MFGs [31]. Also, BSDL and PLRP2 have been
shown to have a synergistic effect on TAG hydrolysis [8].
The Lipid Paradox and Functionality of Bile Salts
The capacity to digest fat is not only incomplete and sub-
optimal at birth due to low pancreatic enzyme levels as
mentioned before, but also due to low intraluminal BS
concentrations. Yet, lipolysis and nutrient lipid absorption
in the term, breast-fed infant are remarkably efficient by
adult standards, considering the amount of lipid an infant
consumes. In essence, several mechanisms have evolved to
“circumvent” this relative immaturity of the pancreatic,
intestinal, and hepatobiliary systems.
BSs are highly relevant for the dispersion, enzymatic
activity, and solubilization of the hydrolysis products into
an absorbable form, with an inadequate supply to the gut
resulting in suboptimal lipid absorption. Intraluminal BS
levels above the critical micellar concentration (CMC;
∼4 mM) are required for a proper absorption of dietary
lipids and/or lipophilic compounds. Hence, a critical BS
mass is required for optimal fat absorption [152].
At birth, the human fetus switches from a glucose-
dominated to a lipid-dominated energy supply. The proper
digestion and absorption of lipid is hence important, not
only to meet energy requirements but also for optimal
growth and neuronal development [91]. Fat intake in
newborns (2.5–3.5 g/kg BW/day) is three to five times
higher compared to adults. It seems, therefore, a paradox
that the main enzyme involved in TAG digestion in adults,
i.e., PTL, is virtually absent at birth. Also, luminal BS levels
reach only 1–5 mM during established fat absorption,
whereas in adults, levels of up to 30 mM can be reached
after a fatty meal. The CMC of BSs, needed for solubiliza-
tion of the products of lipid digestion and its subsequent
absorption, can thus hardly be reached during infancy.
Hence, both digestion and absorption are expected to be
different (i.e., lower) from adults in the newborn. However,
despite this paradox, fat absorption in newborns fed with
unpasteurized human milk is more efficient than one would
expect [8, 91, 151].
Bile is very important for the absorption of fat and
lipophilic substances. Although up to about 50 % of fat
can be absorbed in the absence of bile, this fat is then
absorbed as FFAs, predominantly through direct portal ab-
sorption and avoiding the lymphatic route that is normal for
long-chain TAG [29, 54]. Moreover, the FAs tend to accu-
mulate in the small intestinal mucosa [54, 125]. The absorp-
tion of other lipid-soluble substances, such as cholesterol,
vitamin D, vitamin K, and carotene, are almost completely
dependent on the presence of bile [116, 130, 136]. Bile is
secreted from the liver and temporarily stored and concen-
trated in the gall bladder. It is a mixture of mainly BSs, PLs,
cholesterol, and bicarbonate. Bile’s constituents are highly
surface-active, which is essential for its function as an
emulsifier for any non-emulsified fat that enters the small
intestine and to ensure a large accessible surface area for the
lipases [70, 72, 73]. Moreover, the BSs and PLs form
micelles. By solubilization, these micelles are able to re-
move lipolytic reaction products and other emulsifiers from
the droplet surfaces, which would otherwise form a surface
barrier for the lipases. These micelles are also needed for
PTL. The active site of PTL is covered by a molecular lid
that can only be fully opened by forming a complex with its
colipase and appropriate micellar species, such as bile
micelles, and in solution possibly also requires the presence
of a lipid/water interface [16, 67, 124]. Finally, the BS
micelles can transport the released MAGs and FAs through
the mucous lining of the small intestine, making them avail-
able for absorption [99, 141]. This is especially important
for the LCFA and MAGs because they are insoluble in water
at body temperature [99].
Compared to adults, infants have a different composition
of their BS pool. Secondary BSs are virtually absent in
newborns which lack an established gut flora and hence
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substantial 7-dehydroxylation. In contrast to adults, BSs in
infants are mainly taurine-conjugated [71]. BSs are synthe-
sized from cholesterol by the hepatocytes. Despite an in-
creased rate of synthesis in infants, the BS pool size is
smaller due to both incomplete intestinal recovery and he-
patic extraction. This results in considerably higher plasma
BS levels in infants which are until an age of 6–8 months
typically three to ten times higher than in adults [71, 152].
About 50 % of the FAs in human milk are saturated; these
require BSs for their solubilization and subsequent absorp-
tion [101]. Thus, infants with bile acid malabsorption may
run into digestive problems regarding their lipid dietary
intake.
Bile Salt Transport and Enterohepatic Recycling
Ileal active BS transport is absent at birth and develops
during the first postnatal weeks and was shown in the rat
to develop during the third postnatal week [69]. The active
BS-transporting capacity increases with age, which was
suggested to relate to a change in the microvillus membrane
lipid composition (more unsaturated FA) at unchanged PL
levels and a decrease in membrane fluidity due to an in-
creased cholesterol content. To what extent dietary effects
contribute to this association remains to be elucidated [69].
As active BS transport is compromised and confined to
the distal ileum in early life, enterohepatic BS cycling is less
efficient. Despite of this, no excessive BS loss in stool is
observed, although relative to their BW, fecal BS loss in
infants may be higher or similar to that of adults [71]. Apart
from BSs, the stool of breast-fed infants consists mainly of
bacteria and unabsorbed FA, as no substantial amounts of
insoluble fibers are ingested.
The postnatal development of the enterohepatic circula-
tion entails an increase in the BS pool, which correlates with
increased BS levels in the gut and with an improved fat
absorption. The increased BS pool size leads to an efficient
absorption as lipolysis, solubilization, and absorption of
dietary lipid are best facilitated. The observation that fat
absorption from fresh human milk is markedly more effi-
cient than from formula milk might be directly related to the
finding that breast-fed infants show a larger BS pool and
higher intraluminal BS concentrations compared to formula-
fed infants, both at 11 and 35 days of age [152]. The
recycling frequency of BS was shown to be a major deter-
minant of BS pool size: a reduced recycling frequency, for
example, due to a slower bowel transit time, has been shown
to increase the BS pool [152]. Hence, a rapid small bowel
transit would quickly return BS to the liver and in this way
reduces the stimulus for BS synthesis. The latter mechanism
might be operational in the breast-fed infants. It is not clear
if this mechanism of stimulated BS synthesis by a reduced
BS recycling frequency explains or contributes to the ob-
served larger BS pool and the more efficient fat absorption
in breast-fed infants compared to formula-fed infants [144].
Hence, the maturation of fat absorption in human neonates
is possibly linked to the developmental changes which are
observed in BS composition and pool size.
Changes in Enzyme and Bile Acid Functionality
During Maturation
With increasing age towards weaning and the introduction
of solid foods, BS secretion increases due to liver function
maturation and PLRP2, BSDL, and BSSL become less
important to TAG digestion. This coincides with PTL be-
coming the dominant TAG lipase. The increasing intralumi-
nal BS levels attenuate PLRP2 and BSDL activity as both
enzymes are BS-sensitive. At the same time, the higher
intraluminal BS levels enable an efficient FA absorption [8].
However, until weaning, with milk as the main feed and
PLRP2 acting together with BSSL, the synergistic effect of
the combination is likely to compensate BS levels to main-
tain neonatal capacity to digest fat. Fat-digestive capacity is
thus safeguarded, which would otherwise become a limiting
factor in energy utilization [8].
Bile Salt-Stimulated Lipase and Lipid Architecture
Facilitate Lipid Digestion
As stated before, digestion and absorption of fat from hu-
man milk has been found to be more efficient compared to
that of IF. Digestion is a result of the interdependence of the
nutritional composition and the corresponding hydrolytic
enzymes. In this context, human milk may facilitate the
digestibility of its lipids via distinct mechanisms.
To support the absorption of TAG, cholesterol, and fat-
soluble vitamins in infancy, human milk contains BSSL,
which is very similar to BSDL. BSSL is inactive in the milk
and in the stomach, but survives the stomach’s acidic and
proteolytic environment. It is activated by bile in the small
intestine. It has been shown in rats that BSSL binds to the
intestinal mucosa and efficiently hydrolyses cholesterol esters,
which improves the overall absorption of cholesterol [49].
In addition, the MFGM of human milk has a high PL
content which may contribute to BSSL activation by bile.
As BSSL is active on all positions of the TAG molecule,
BSSL might also be functional in further hydrolyzing the
DAG formed as the endpoint of GL digestion. However, the
complex interplay of the different lipases, their substrates, and
the infant’s digestive physiology remains to be clarified [148].
Lipolysis by the water-soluble lipases occurs usually in the
presence of an emulsifier at the oil/water interface. The rate
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and extent of lipolysis depends, next to the presence of en-
dogenous factors like PLA2, BSs, and colipase, also on the
droplet characteristics. These include the area of the TAG
surface available to the lipase, primarily determined by the
droplet size, and on the emulsifier type [13, 17, 23, 24, 28,
109, 111]. However, the relation between these droplet char-
acteristics and their digestion is anything but simple. Lipolytic
activity is clearly increased when a higher accessible surface
area is available; however, the emulsifier appears to be of at
least equal importance [21, 109, 111]. In human milk, this
“emulsifier” is the MFGM, consisting of PL and membrane
proteins, whereas in IF, this is usually only protein. The results
from in vivo gastric aspirates studies suggest that GL activity
could be affected by the droplet’s size and interface composi-
tion of theMFG, as BSSL is unlikely to be active under gastric
conditions [12, 128]. Although emulsifiers could potentially
influence the lipolysis rate by inhibiting or promoting the
access of the enzyme to the TAGs, this effect seems to be
relatively small [123].
Dependent on the emulsifier type, declining pH and
enzymatic activity can destabilize the emulsion droplets,
which results in flocculation of the droplets [103–105,
142]. This could lead to a fat layer on top of the gastric
contents that delays the entrance and detection of fat in the
small intestine [53, 74, 103, 104, 154]. It has been shown
that, although PL-stabilized emulsions strongly aggregate
under gastric conditions, native cow milk MFGs remain
dispersed under gastric conditions of lipolysis [123]. Appar-
ently, the protein structure of the MFGM can keep the fat
droplets separated, without inhibiting gastric lipolysis. Fur-
thermore, for intact cow’s milk, it was found that the MFGs
flocculate together with the caseins to form a soft gel in the
stomach, which sediments due to its high protein content
[142]. Whether this is also applicable for human milk, with
its higher fat and lower protein content, remains to be
elucidated.
Lipolytic Enzymes for the In Vitro Study of Lipid
Digestion in Infancy
In vitro approaches, which have been built on the available
clinical data on luminal biochemistry, offer an opportunity
to generate insights in infant digestion. Based on the com-
plexity of both the substrate and the involved lipolytic
enzymes, the in vitro investigation of lipid digestion during
infancy has proven particularly challenging.
In order to realistically simulate the lipid digestion of the
newborn, GL, PTL, BSDL, and PLRP2 should be present in
physiological amounts. However, this approach is chal-
lenged by the fact that human GL and PLRP2 are not
commercially available. Furthermore, commercial pancrea-
tin may not contain PTL, BSDL, and PLRP2 in
concentrations that are adapted to human infant levels
[149]. It has been found that porcine pancreatic extracts do
contain BSDL [22]. However, levels of BSDL and PLRP2
in infants are not exactly known [8].
Active human GL has been successfully produced in
insect and yeast cells [4, 35]. However, the yield with these
methods appeared to be too low for commercial exploita-
tion. Recombinant dog GL was produced in transgenic
plants at high levels [59]. However, the cultivation of ge-
netically modified plants has been a controversial subject in
the public opinion. As a result, 40,000 m2 of GL-expressing
corn that were grown to substitute cystic fibrosis patients
were destroyed in 2003 [98].
Due to the lack of availability of human GL, several
alternative enzymes have been evaluated. Fungal lipases,
such as F-AP15 from Rhizopus orizae (Amano Enzyme
Inc.) and lipase A “Amano” 12 from Aspergillus niger
(Amano Enzyme Inc.), are, for example, active at a low
pH. However, these enzymes do not have the same posi-
tional and FA chain length specificity as the human GL. In
addition, their activity might be high also at neutral pH, thus
having a larger contribution to lipolysis in the small intestine
as compared to human GL. Commercially available pregas-
tric or lingual lipase from lamb or calf, which are used to
hydrolyze fat and produce a specific flavor in some cheeses,
may offer alternative lipase sources [20]. These enzymes
belong to the acid lipase gene family like human GL and are
structurally and functionally similar. They are active at
lower pH values and also have a preference for the sn-3
position. However, the FA chain length specificity and the
pH activity profile are different, and they are not as acid-
stable as human GL [117]. Recently, approaches to obtain
sufficient quantities of GL were reported. For instance,
rabbit GL has been proposed as a replacement for human
GL [36]. In addition, the human GL has been successfully
expressed in Nicotiana benthamiana, a close relative of the
common tobacco plant [145].
It can be concluded that the simulation of lipid diges-
tion under infant conditions with realistic enzyme activi-
ties is hampered by the availability of GL and PLRP2 and
the lacking knowledge on the exact activities of PLRP2
and BSDL in the infant. The question is whether or not it
is necessary to precisely reproduce these enzyme activities
to study infant lipid digestion. In essence, there is no
simple answer as this will always depend on the research
question at hand. For example, it has been shown that the
specific activities of GL and PTL may result in a higher
availability of PA that is predominantly present at the sn-2
position of human milk fat [90]. Even though GL contrib-
utes very little to sn-2 lipolysis and PTL activity in infants
is low, intestinal lipolysis can be taken over by BSDL and
PLRP2, which are capable of complete TAG hydrolysis.
However, although GL may not have the most important
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contribution from a quantitative point of view, GL’s ste-
reospecificity has functional implications and it has also
been proposed to be relevant for the action of pancreatic
lipases [56, 90, 119].
BSDL and PLRP2 have specific activities that could be
crucial for the investigation of lipids other than TAGs.
BSDL is a carboxyl esterase with activity against a variety
of substrates, such as TAGs, cholesterol esters, galactoli-
pids, ceramides, and PLs [52, 92]. PLRP2 not only hydrol-
yses TAGs but also PLs and galactolipids [46, 48]. Given
this overlap in substrate specificity, BSDL could be used as
an approximation to the in vivo conditions as the main
pancreatic lipase if PLRP2 is not available. However, BSDL
does not appear to be able to hydrolyze the MFG by itself as
BSDL and PLRP2 work synergistically [8].
In Vitro Models Mimic Digestive Physiology
Two cardinal types of in vitro models—static and dynamic—
can be distinguished, with a broad range of intermediates that
can be further divided according to their approach. In static
models, the addition of digestive juices occurs in one bolus.
The mixing of chyme and digestive juices usually occurs in a
single compartment by stirring. More realistic simulations of
digestion processes are obtained in dynamic models, in which
the secretion of digestive juices is gradual. In some dynamic
models, peristaltic movement can also be simulated. In ad-
vanced models, various physiological units are combined
together in consecutive order, e.g., the stomach, the small
intestine, and the colon. Advanced dynamic models may also
remove products of digestion from the intestinal lumen to
simulate absorption and prevent product inhibition of the
enzymes.
Lipid digestion is most often measured by means of
chemical quantification of FFAs by titration or by chroma-
tography. The measurement of TAG digestion products by,
e.g., mass spectroscopy or in situ densitometric analysis
yields more detailed insights [134]. Radiolabeled substrates
are also used to improve the identification of products
formed [79].
Optical microscopy, ζ-potential, cryo-transmission elec-
tron microscopy, and particle size analysis can give mecha-
nistic insight into the physical nature of lipolysis [108]. The
recent introduction of multiplex coherent anti-Stokes Raman
scattering microspectroscopy has brought a promising new
means to continuously image the digestion process [45].
Lipid digestion models have been frequently used to
investigate, for example, the interaction of oral drugs with
foods, digestion of lipid-based drug delivery systems, and
controlled digestion of emulsion-based systems in the re-
search of satiety [15, 47, 50, 86, 108].
Single-Phase Static Models
The pH-stat method is the most widely used method to inves-
tigate lipid digestion [88, 108]. The method is based on
measurements of the amount of FFA released from lipids
(usually TAG) after lipase addition at a fixed pH. The method
usually simulates the conditions within the small intestine
with physiological amounts of PTL, colipase, BSs, and min-
erals. The reaction takes place in a single thermostatically
controlled vessel. The release of FFAs as a result of lipolysis
will subsequently liberate protons that would acidify the ves-
sel. The pH is kept constant by continuous titration with a
base, and the amount of base needed is proportional to the
amount of FFA released. The method has similarities to tradi-
tional lipase activity assays [39]. Most FFAs have a high pKa
value, which can make them partly ionized and titratable
under assay conditions. Therefore, back titration at the end
of the experiment at high pH is often needed for the estimation
of total FFA formed [51, 156].
This relatively simple method allows the investigation
of the impact of different factors on the rate of lipolysis
by PTL, without the complicating effects of pH varia-
tion, gradual dilution, and gradual increase in the en-
zyme concentration. Factors that have been studied
among others are the type of TAG, amount of calcium,
BS dependency, droplet size, and emulsifier type [3, 10,
28, 44, 68, 75, 76, 134, 135].
The titration method provides no details on individual
lipid digestion products as the measured response is inde-
pendent from the type of FFA. It has been shown that a
combination of the pH-stat method with gas chromatogra-
phy analysis not only enabled the monitoring of MAG and
DAG concentrations, but also demonstrated that the amount
of FFA released during lipolysis could be underestimated in
emulsions stabilized by whey protein isolate [66].
FFA released during lipolysis can accumulate on the emul-
sion interface and therewith inhibit PTL by a process called
product inhibition [34, 133]. In vivo, solubilization of FFA in
BS-PL micelles together with MAG is believed to be the most
effective way of removing the FFA from the emulsion inter-
face [160]. Continuous addition of calcium has been shown to
prevent product inhibition in vitro, probably through the pre-
cipitation of released FFA [50, 159]. This addition extends the
dynamic range of the method. The efficacy of FFA removal
will, however, depend on the FA type. Moreover, a too effi-
cient binding of FFA to calcium ions might change the prop-
erties of the bile micelles, which during in vivo digestion
become filled with the released lipolytic hydrolysis products.
A different approach to prevent FFA accumulation on the
emulsion interface is the addition of FFA-free bovine serum
albumin to the reaction medium [28].
Since the pH-stat method usually focuses on small intes-
tinal lipolysis, being the main locus of lipid digestion in
70 Food Dig. (2012) 3:63–77
adults, the processes that take place in the stomach phase are
usually ignored. It has been shown, however, that the com-
plete digestion of human milk fat in vitro requires also GL
[19]. In addition, the influence of gastric lipolysis on small
intestinal lipolysis can be significant [19, 28, 56]. This
applies especially to infants where the relative contribution
of the intestinal phase to overall lipid digestion is lower due
to the low PTL. An in vitro study of milk lipid digestion in
infancy should, therefore, encompass a gastric phase before
the intestinal phase.
Sequential-Phase Static Models
A sequential approach in the pH-stat setting has been devel-
oped, in which distinct gastric and intestinal phases were
incorporated [40]. Incubation with a gastric juice at pH 5.5
for half an hour was followed by incubation with a pancre-
atic juice/bile solution at pH 6.25 for an hour in this setting.
The conditions used were based on the analysis of gastric
and duodenal aspirates at 50 % of gastric emptying of a
liquid preparation for enteral nutrition. The method is ap-
plied, for example, to study lipolysis of test meals con-
taining various fats, to predict the efficacy of a lipase
inhibitor, to study the effects of lipolysis on the solubility
of hydrophobic drugs formulated with lipids, and recently,
to compare the lipolytic potential of crude animal diges-
tive lipases with that of human gastric and pancreatic
juices and that of purified human digestive lipases [36,
41]. In this method, the analysis of FFA, MAG, DAG, and
TAG was performed using thin-layer chromatography and
flame ionization detection. The measurement of released
FFA is, therefore, not dependent on titration. As a next
step, this method has been combined with Caco-2 mono-
layers to investigate the intestinal absorption and lipid
metabolism of the lipolysis products in the intestinal epi-
thelium [8, 148]. It was found that the emulsion compo-
sition influenced the activation of lipid metabolism and
TAG secretion by the epithelial cells.
Static model systems are usually designed dedicated to a
specific research question and improve mechanistic inter-
pretability by avoiding addition of parameters, such as grad-
ual pH variation and dilution. However, since the number of
simulated parameters is limited, their predictability towards
the complex in vivo situation may remain limited. The
sequential-phase model, however, has been shown to have
predictive power towards the in vivo situation in the case of
the action of a lipase inhibitor [41]. Static methods exclude
per definition the dynamic addition of fresh digestive juices
and the removal of digestion products, simulated digestive
juices, and liquid volume. The proteases which are present
in, for example, crude pancreatin can also degrade the lipase
and other digestive enzymes.
Dynamic Models
In vivo, the conditions change considerably along the gut in
space and time. Mixing and propagation occurs by contrac-
tions of the gastric and intestinal walls, while the pyloric
sphincter selectively allows food components to pass based
on feedback mechanisms and particle size. This causes the
gastric content to be gradually emptied from the stomach.
During gastric residence, the meal is mixed and diluted with
saliva and gastric secretions. The pH is not constant but
increases due to the buffer capacity of the meal during intake,
after which it decreases due to the secretion of gastric acid.
Enzyme activities in time are the result of both their output and
the gastric pH in time. While the gastric content enters the
duodenum, it is mixed with bile and pancreatic secretions. The
gastric pH is neutralized by bicarbonate to accommodate
duodenal enzyme activities and bile action, while changing
the ionic state and solubility of molecules. This is crucial for
the formation of mixed micelles, comprising of BSs, FAs,
MAGs, PLs, and cholesterol, which provide a transport vehi-
cle preceding the absorption of lipophilic compounds. Besides
providing the body with nutrients, the removal of digestive
products by transport through the gut wall prevents the inhi-
bition of enzyme activity by their digestive products. Water is
also reabsorbed, which concentrates the chyme.
Dynamic models aim to simulate these processes more
realistically than static models, which make them more com-
plex and labor-intensive. However, this is well compensated
by their higher predictive power and broader applicability. The
basic dynamic models are based on a series of stirred vessels
connected by pumps (Fig. 3). These models have been
designed to study antacids [146], the survival of probiotics,
and the interaction of ingested compounds with the intestinal
microbial ecosystem [100, 115]. Gastric dynamic models were
designed to study the gastric behavior of food and pharma-
ceuticals with realistic physical and mechanical aspects. The
dynamic gastric model (DGM) [153] consists of a funnel-
shaped vessel that mimics the upper part of the stomach. Mild
mixing is obtained by slow contractions of a flexible mem-
brane that acts as the gastric wall. The antral motility is
mimicked with a plunger system that mixes and grinds the
chyme before emptying from the gastric compartment. In the
DGM, F-AP15 (Amano Enzyme Inc.) is used as GL substitute.
Another model that simulates the physical properties of the
stomach is the human gastric simulator (HGS) [85]. This
model creates peristaltic movements by moving rollers along
a flexible artificial stomach wall. In the HGS, lipase A
“Amano” 12 (Amano Enzyme Inc.) is used as GL substitute.
These gastric models are useful to study the gastric diges-
tion and aspects, such as particle breakdown, rheology, phase
separation, and release of nutrients and pharmaceuticals.
Both the gastric and the small intestinal digestive pro-
cesses are simulated in the TNO gastrointestinal model
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(TIM) (Fig. 4), which simulates the successive dynamic
conditions in the gastrointestinal tract [113]. The system is
controlled following specific digestive protocols that in-
clude parameters in time for meal transit, pH profiles in
the different compartments, temperature, secretion of diges-
tive fluids, and removal rate of water and digestion products.
F-AP15 (Amano Enzyme Inc.) is used as a GL substitute,
while pancreatin is used as a source of pancreatic enzymes.
The secreted bile is obtained from slaughterhouse pigs.
It offers the possibility to simulate the GI conditions in
infants and adults and study age-dependent digestion [25].
Although this model lacks a realistic gut wall that selectively
transports compounds by active or facilitated transport sys-
tems, devices are included in the system to study the removal
of digested and solubilized compounds from the GI lumen. A
dialysis system removes water-solubilized molecules below a
specific molecular weight cutoff. A filtration system removes
lipid-soluble products and allows mixed micelles and small
vesicles to pass. Lipid droplets are retained in the lumen of the
intestinal compartments because they are larger than the fil-
tration membrane’s pores. By selectively removing the prod-
ucts of lipid digestion and fat-soluble compounds, the
Fig. 3 Example of a dynamic
system with two stirred vessels.
A stomach vessel, B small
intestine vessel, C influent
vessel, D effluent vessel, E
gastric secretions with acid and
enzymes, F duodenal secretions
with alkali, bile, and pancreatic



























Fig. 4 a Schematic representation of the TIM-1 lipid system. A gastric
compartment, B pyloric sphincter, C duodenum, D peristaltic valve, E
jejunum compartment, F peristaltic valve, G ileum compartment, H
ileocecal valve, I gastric secretion, J duodenal secretion, K bicarbonate
secretion, L prefilter, M filtration membrane, N filtration pump, P pH
electrodes, Q level sensor, R temperature sensor, S pressure sensor. b
the TIM-1 cabinet
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digestibility of various fats and oils and the availability for
absorption, e.g., bioaccessibility, of FAs, nutrients, e.g., fat-
soluble vitamins, and pharmaceuticals can be studied [112].
Subsequently, by combining samples from the TIM system
with intestinal cell lines or segments, intestinal absorption of
the compound of interest can be studied.
Conclusions
Human milk has been shown to have a direct impact on the
development of the infant’s digestive system, which equally
impacts the digestion processes of its primary substrate [96,
97]. However, the mutual interdependencies between both
remain to be elucidated. To date, little is known about the
digestion and absorption of milk TAG and lipids, such as PLs
and cholesterol, which provide functionality beyond energy.
As such, lipids are a key component of the healthy develop-
ment of, e.g., body composition and the nervous and gastro-
intestinal systems. Clinical outcomes linked to the latter,
which are modulated by fat quality and quantity, can only be
tested in clinical trials. The basic mechanisms of infant lipid
digestion, however, can almost exclusively be investigated by
in vitro approaches. The peculiarities of the infant digestive
system—which is significantly different from a miniature
version of the adult digestive system—generate methodolog-
ical challenges. For example, specific enzymes, such as hu-
man GL that are highly relevant for lipid digestion during
infancy, are not yet readily available. Nonetheless, in vitro
systems—ranging from static single phase to complex and
dynamic, multicompartmental systems—can be adequate
approximations of infant digestive conditions for specific
applications. This will allow the investigation of relevant
parameters of human milk lipid digestion during infancy,
which may help to support the further improvement of IFs.
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